These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 34563660

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC, Glintborg D, Timmermann CAG, Nielsen F, Boye H, Madsen JB, Bilenberg N, Grandjean P, Jensen TK, Andersen MS.
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L, Halperin SA, Dzierlenga MW, Skidmore B, Linakis MW, Nakagawa S, Longnecker MP.
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I, Sasaki S, Okada E, Matsuura H, Goudarzi H, Miyashita C, Okada E, Ito YM, Araki A, Kishi R.
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [Abstract] [Full Text] [Related]

  • 27. The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study.
    Itoh S, Yamazaki K, Suyama S, Ikeda-Araki A, Miyashita C, Ait Bamai Y, Kobayashi S, Masuda H, Yamaguchi T, Goudarzi H, Okada E, Kashino I, Saito T, Kishi R.
    Environ Int; 2022 Jan 15; 159():107026. PubMed ID: 34890903
    [Abstract] [Full Text] [Related]

  • 28. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS, Björvang RD, Mucs D, Vinnars MT, Papadogiannakis N, Lindh CH, Andersen CY, Damdimopoulou P.
    Environ Int; 2019 Mar 15; 124():482-492. PubMed ID: 30684806
    [Abstract] [Full Text] [Related]

  • 29. Perfluoroalkyl substances in cord blood and attention deficit/hyperactivity disorder symptoms in seven-year-old children.
    Lien GW, Huang CC, Shiu JS, Chen MH, Hsieh WS, Guo YL, Chen PC.
    Chemosphere; 2016 Aug 15; 156():118-127. PubMed ID: 27174824
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J, Liang H, Tian Y, Yuan W, Xiao H, Hu H, Sun X, Song X, Wen S, Yang L, Ren Y, Miao M.
    Environ Health; 2019 Jun 13; 18(1):53. PubMed ID: 31196101
    [Abstract] [Full Text] [Related]

  • 32. Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.
    Marks KJ, Jeddy Z, Flanders WD, Northstone K, Fraser A, Calafat AM, Kato K, Hartman TJ.
    Reprod Toxicol; 2019 Dec 13; 90():8-14. PubMed ID: 31415809
    [Abstract] [Full Text] [Related]

  • 33. Maternal concentrations of phthalates and Attention-Deficit Hyperactivity Disorder (ADHD-) related symptoms in children aged 2 to 4 years from Odense child cohort.
    Munk Andreasen S, Frederiksen H, Bilenberg N, Andersson AM, Juul A, Kyhl HB, Kold Jensen T.
    Environ Int; 2023 Oct 13; 180():108244. PubMed ID: 37797478
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB, Casas M, Lopez-Espinosa MJ, Ballester F, Iñiguez C, Martinez D, Romaguera D, Fernández-Barrés S, Santa-Marina L, Basterretxea M, Schettgen T, Valvi D, Vioque J, Sunyer J, Vrijheid M.
    Environ Health Perspect; 2017 Sep 20; 125(9):097018. PubMed ID: 28934720
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort.
    Goodman CV, Till C, Green R, El-Sabbagh J, Arbuckle TE, Hornung R, Lanphear B, Seguin JR, Booij L, Fisher M, Muckle G, Bouchard MF, Ashley-Martin J.
    Neurotoxicol Teratol; 2023 Sep 20; 98():107181. PubMed ID: 37178772
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.